These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 2307929

  • 1. Structural requirements for pairing of alpha and beta chains in HLA-DR and HLA-DP molecules.
    Karp DR, Teletski CL, Jaraquemada D, Maloy WL, Coligan JE, Long EO.
    J Exp Med; 1990 Mar 01; 171(3):615-28. PubMed ID: 2307929
    [Abstract] [Full Text] [Related]

  • 2. A novel family of human leukocyte antigen class II receptors may have its origin in archaic human species.
    Temme S, Zacharias M, Neumann J, Wohlfromm S, König A, Temme N, Springer S, Trowsdale J, Koch N.
    J Biol Chem; 2014 Jan 10; 289(2):639-53. PubMed ID: 24214983
    [Abstract] [Full Text] [Related]

  • 3. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
    Diedrichs M, Schendel DJ.
    J Immunol; 1989 May 01; 142(9):3275-80. PubMed ID: 2785139
    [Abstract] [Full Text] [Related]

  • 4. Modulation of HLA class II antigen expression by transfection of sense and antisense DR alpha cDNA.
    Lotteau V, Sands J, Teyton L, Turmel P, Charron D, Strominger JL.
    J Exp Med; 1989 Jan 01; 169(1):351-6. PubMed ID: 2462612
    [Abstract] [Full Text] [Related]

  • 5. The properties of the single chicken MHC classical class II alpha chain ( B-LA) gene indicate an ancient origin for the DR/E-like isotype of class II molecules.
    Salomonsen J, Marston D, Avila D, Bumstead N, Johansson B, Juul-Madsen H, Olesen GD, Riegert P, Skjødt K, Vainio O, Wiles MV, Kaufman J.
    Immunogenetics; 2003 Dec 01; 55(9):605-14. PubMed ID: 14608490
    [Abstract] [Full Text] [Related]

  • 6. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
    Karp DR, Teletski CL, Scholl P, Geha R, Long EO.
    Nature; 1990 Aug 02; 346(6283):474-6. PubMed ID: 2377209
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules.
    De Lerma Barbaro A, Sartoris S, Tosi G, Nicolis M, Accolla RS.
    J Immunol; 1994 Nov 15; 153(10):4530-8. PubMed ID: 7525708
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
    Klohe EP, Watts R, Bahl M, Alber C, Yu WY, Anderson R, Silver J, Gregersen PK, Karr RW.
    J Immunol; 1988 Sep 15; 141(6):2158-64. PubMed ID: 2459201
    [Abstract] [Full Text] [Related]

  • 12. Cellular distribution of a mixed MHC class II heterodimer between DRalpha and a chimeric DObeta chain.
    Samaan A, Thibodeau J, Mahana W, Castellino F, Cazenave PA, Kindt TJ.
    Int Immunol; 1999 Jan 15; 11(1):99-111. PubMed ID: 10050678
    [Abstract] [Full Text] [Related]

  • 13. Identification with the monoclonal antibody 26.163 of a determinant shared by the beta chains of the gene products of the HLA-DR, DQ, and DP loci.
    Igarashi M, Gebhard DH, Chen YX, Safai B, Evans RL, Ferrone S.
    Hum Immunol; 1986 Aug 15; 16(4):347-55. PubMed ID: 2428781
    [Abstract] [Full Text] [Related]

  • 14. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C, Delarue F, Hé CJ, Nguyen G, Adida C, Peraldi MN, Sraer JD, Rondeau E.
    Exp Nephrol; 1994 Aug 15; 2(5):306-12. PubMed ID: 7812737
    [Abstract] [Full Text] [Related]

  • 15. Predominant role of amino-terminal sequences in dictating efficiency of class II major histocompatibility complex alpha beta dimer expression.
    Sant AJ, Braunstein NS, Germain RN.
    Proc Natl Acad Sci U S A; 1987 Nov 15; 84(22):8065-9. PubMed ID: 3120183
    [Abstract] [Full Text] [Related]

  • 16. A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing.
    Lotteau V, Teyton L, Burroughs D, Charron D.
    Nature; 1987 Nov 15; 329(6137):339-41. PubMed ID: 3306409
    [Abstract] [Full Text] [Related]

  • 17. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I, Gulle H, Wolf HM, Maris M, Eggenbauer H, Eibl MM.
    J Exp Med; 1995 Apr 01; 181(4):1411-23. PubMed ID: 7699327
    [Abstract] [Full Text] [Related]

  • 18. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
    Sakai K, Takiguchi M, Mori S, Kobori O, Morioka Y, Inoko H, Sekiguchi M, Kano K.
    J Natl Cancer Inst; 1987 Nov 01; 79(5):923-32. PubMed ID: 2960847
    [Abstract] [Full Text] [Related]

  • 19. Isolation and allelic polymorphism of cDNA clones and genomic clones of HLA-DP heavy and light chains.
    Ando A, Inoko H, Kimura M, Ogata S, Tsuji K.
    Hum Immunol; 1986 Nov 01; 17(3):355-67. PubMed ID: 2878910
    [Abstract] [Full Text] [Related]

  • 20. Invariant chain influences post-translational processing of HLA-DR molecules.
    Schaiff WT, Hruska KA, Bono C, Shuman S, Schwartz BD.
    J Immunol; 1991 Jul 15; 147(2):603-8. PubMed ID: 2071896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.